Share Price and Basic Stock Data
Last Updated: November 28, 2025, 8:05 am
| PEG Ratio | 14.38 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Galaxy Surfactants Ltd operates within the oil drilling and exploration industry, with a reported market capitalization of ₹7,165 Cr. The company’s share price stood at ₹2,022. For the fiscal year ending March 2023, Galaxy reported sales of ₹4,462 Cr, a significant increase from ₹3,684 Cr in FY 2022. This growth trajectory reflects a compound annual growth rate (CAGR) of approximately 20% over the last five years, highlighting the company’s ability to capitalize on increasing demand for surfactants. However, the revenue for FY 2024 is anticipated to decline to ₹3,792 Cr, indicating potential volatility in market conditions. The trailing twelve months (TTM) sales reported at ₹4,791 Cr suggests that the company has regained momentum, with a notable sales increase in the recent quarters, particularly rising from ₹929 Cr in Mar 2024 to ₹1,145 Cr in Mar 2025. This upward trend in sales is crucial for sustaining its competitive edge in the surfactants market, which is characterized by fluctuating raw material prices and evolving consumer preferences.
Profitability and Efficiency Metrics
Galaxy Surfactants’ profitability metrics reveal a mixed performance. The operating profit margin (OPM) for the fiscal year 2025 stood at 11%, a slight decrease from 12% in FY 2024, indicating challenges in maintaining profitability amidst rising operational costs. The company’s net profit for FY 2025 was reported at ₹305 Cr, which reflects a marginal increase from ₹301 Cr in FY 2024. The return on equity (ROE) was recorded at 12.90%, slightly lower than the previous year’s 13.83%, showcasing a decline in profitability relative to shareholders’ equity. Moreover, the interest coverage ratio (ICR) of 26.50x demonstrates robust operational efficiency, suggesting that the company can comfortably meet its interest obligations. However, the cash conversion cycle (CCC) of 73 days indicates a need for improvement in managing working capital, as it remains consistent with the previous year, highlighting potential inefficiencies in inventory management and collections.
Balance Sheet Strength and Financial Ratios
Galaxy Surfactants boasts a strong balance sheet with total assets reported at ₹3,450 Cr for FY 2025. The company’s reserves have increased to ₹2,327 Cr, reflecting its solid retained earnings and financial prudence. With borrowings at a manageable ₹210 Cr, the debt-to-equity ratio remains low at 0.06, indicating minimal leverage and a lower financial risk profile. The current ratio of 2.14x suggests a comfortable liquidity position, allowing the company to meet short-term obligations effectively. Furthermore, the price-to-book value (P/BV) ratio stood at 3.08x, indicating that market participants are willing to pay a premium for the company’s shares relative to its book value, reflecting investor confidence. However, the return on capital employed (ROCE) has seen a decline to 16.09% from 17.21%, suggesting that while the company maintains a solid asset base, it may need to focus on optimizing its capital efficiency to enhance returns on investments further.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Galaxy Surfactants is indicative of strong promoter confidence, with promoters holding 70.91% of the total shares as of Mar 2025. This high level of ownership suggests a commitment to the company’s long-term strategy. Foreign institutional investors (FIIs) have increased their stake to 4.10%, while domestic institutional investors (DIIs) hold 12.94%. The public shareholding stands at 11.96%, reflecting a relatively stable investor base. Notably, the number of shareholders has decreased to 49,547, down from 64,787 in Dec 2022, which may indicate consolidation or a shift in investor sentiment. The consistent presence of FIIs and DIIs in the shareholding structure underlines a level of confidence in the company’s fundamentals and growth prospects. However, the declining number of shareholders could indicate potential concerns about liquidity or market conditions affecting retail investor participation.
Outlook, Risks, and Final Insight
Looking ahead, Galaxy Surfactants faces both opportunities for growth and risks that could impact performance. The ongoing demand for eco-friendly surfactants presents a potential growth avenue, particularly as industries increasingly prioritize sustainability. However, the company must navigate challenges such as fluctuating raw material prices and potential regulatory changes that could affect production costs. Additionally, while the company’s low debt levels and strong liquidity support its operational stability, any slowdown in global economic conditions could adversely impact sales and profitability. Investors should monitor the company’s efforts to improve operational efficiencies and manage working capital effectively. Overall, Galaxy Surfactants is well-positioned in a growing industry, but maintaining profitability amidst market volatility will be crucial for sustaining investor confidence and achieving long-term growth.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Galaxy Surfactants Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat Natural Resources Ltd | 1,181 Cr. | 92.0 | 97.3/16.2 | 743 | 14.1 | 0.00 % | 0.56 % | 2.87 % | 10.0 |
| Dolphin Offshore Enterprises (India) Ltd | 1,399 Cr. | 350 | 608/200 | 26.4 | 75.5 | 0.00 % | 14.7 % | 18.7 % | 1.00 |
| Deep Energy Resources Ltd | 999 Cr. | 312 | / | 694 | 121 | 0.00 % | 0.39 % | 0.35 % | 10.0 |
| Selan Explorations Technology Ltd | 881 Cr. | 580 | 969/475 | 13.4 | 309 | 0.00 % | 22.8 % | 17.2 % | 10.0 |
| Oil India Ltd | 67,862 Cr. | 417 | 504/322 | 11.4 | 346 | 2.76 % | 12.9 % | 13.3 % | 10.0 |
| Industry Average | 32,776.08 Cr | 420.79 | 147.04 | 600.59 | 1.01% | 10.56% | 9.87% | 6.85 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,159 | 1,232 | 1,085 | 980 | 942 | 983 | 940 | 929 | 974 | 1,063 | 1,042 | 1,145 | 1,278 |
| Expenses | 1,011 | 1,100 | 931 | 845 | 819 | 858 | 828 | 827 | 850 | 935 | 936 | 1,018 | 1,154 |
| Operating Profit | 148 | 132 | 154 | 135 | 123 | 125 | 112 | 102 | 124 | 128 | 106 | 127 | 124 |
| OPM % | 13% | 11% | 14% | 14% | 13% | 13% | 12% | 11% | 13% | 12% | 10% | 11% | 10% |
| Other Income | -2 | 1 | 4 | 7 | 2 | 3 | 6 | 24 | 5 | 9 | 4 | 8 | 11 |
| Interest | 4 | 6 | 6 | 6 | 6 | 5 | 6 | 5 | 4 | 4 | 5 | 6 | 7 |
| Depreciation | 19 | 20 | 22 | 23 | 24 | 25 | 25 | 26 | 27 | 28 | 28 | 28 | 29 |
| Profit before tax | 123 | 107 | 131 | 113 | 96 | 98 | 88 | 94 | 99 | 104 | 77 | 100 | 99 |
| Tax % | 18% | 21% | 19% | 20% | 22% | 21% | 19% | 18% | 19% | 19% | 16% | 24% | 20% |
| Net Profit | 100 | 84 | 106 | 91 | 75 | 77 | 71 | 78 | 80 | 85 | 65 | 76 | 79 |
| EPS in Rs | 28.31 | 23.66 | 29.96 | 25.53 | 21.20 | 21.84 | 20.13 | 21.86 | 22.48 | 23.89 | 18.22 | 21.40 | 22.42 |
Last Updated: August 20, 2025, 10:40 am
Below is a detailed analysis of the quarterly data for Galaxy Surfactants Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 1,278.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,145.00 Cr. (Mar 2025) to 1,278.00 Cr., marking an increase of 133.00 Cr..
- For Expenses, as of Jun 2025, the value is 1,154.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,018.00 Cr. (Mar 2025) to 1,154.00 Cr., marking an increase of 136.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 124.00 Cr.. The value appears to be declining and may need further review. It has decreased from 127.00 Cr. (Mar 2025) to 124.00 Cr., marking a decrease of 3.00 Cr..
- For OPM %, as of Jun 2025, the value is 10.00%. The value appears to be declining and may need further review. It has decreased from 11.00% (Mar 2025) to 10.00%, marking a decrease of 1.00%.
- For Other Income, as of Jun 2025, the value is 11.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2025) to 11.00 Cr., marking an increase of 3.00 Cr..
- For Interest, as of Jun 2025, the value is 7.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6.00 Cr. (Mar 2025) to 7.00 Cr., marking an increase of 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 29.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 28.00 Cr. (Mar 2025) to 29.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 99.00 Cr.. The value appears to be declining and may need further review. It has decreased from 100.00 Cr. (Mar 2025) to 99.00 Cr., marking a decrease of 1.00 Cr..
- For Tax %, as of Jun 2025, the value is 20.00%. The value appears to be improving (decreasing) as expected. It has decreased from 24.00% (Mar 2025) to 20.00%, marking a decrease of 4.00%.
- For Net Profit, as of Jun 2025, the value is 79.00 Cr.. The value appears strong and on an upward trend. It has increased from 76.00 Cr. (Mar 2025) to 79.00 Cr., marking an increase of 3.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 22.42. The value appears strong and on an upward trend. It has increased from 21.40 (Mar 2025) to 22.42, marking an increase of 1.02.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 5:22 am
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,870 | 1,799 | 2,158 | 2,432 | 2,761 | 2,595 | 2,782 | 3,684 | 4,462 | 3,792 | 4,221 | 4,791 |
| Expenses | 1,681 | 1,563 | 1,886 | 2,144 | 2,408 | 2,226 | 2,334 | 3,284 | 3,894 | 3,330 | 3,737 | 4,324 |
| Operating Profit | 190 | 236 | 271 | 288 | 353 | 369 | 449 | 401 | 568 | 462 | 484 | 467 |
| OPM % | 10% | 13% | 13% | 12% | 13% | 14% | 16% | 11% | 13% | 12% | 11% | 10% |
| Other Income | 2 | 6 | 10 | 10 | 5 | 6 | 11 | 13 | 10 | 35 | 26 | 29 |
| Interest | 34 | 34 | 27 | 31 | 30 | 24 | 13 | 13 | 22 | 22 | 19 | 25 |
| Depreciation | 45 | 45 | 47 | 49 | 51 | 62 | 74 | 71 | 83 | 100 | 110 | 115 |
| Profit before tax | 112 | 163 | 207 | 219 | 277 | 289 | 372 | 329 | 473 | 375 | 380 | 355 |
| Tax % | 40% | 37% | 29% | 28% | 31% | 20% | 19% | 20% | 19% | 20% | 20% | |
| Net Profit | 67 | 103 | 148 | 158 | 191 | 230 | 302 | 263 | 381 | 301 | 305 | 286 |
| EPS in Rs | 19.03 | 28.97 | 41.64 | 44.57 | 53.87 | 64.99 | 85.22 | 74.12 | 107.46 | 85.03 | 86.00 | 80.79 |
| Dividend Payout % | 21% | 31% | 14% | 16% | 15% | 22% | 21% | 24% | 20% | 26% | 5% |
YoY Net Profit Growth
| Year | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 53.73% | 43.69% | 6.76% | 20.89% | 20.42% | 31.30% | -12.91% | 44.87% | -21.00% | 1.33% |
| Change in YoY Net Profit Growth (%) | 0.00% | -10.04% | -36.93% | 14.13% | -0.47% | 10.89% | -44.22% | 57.78% | -65.86% | 22.33% |
Galaxy Surfactants Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2015-2016 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 10% |
| 3 Years: | 5% |
| TTM: | 18% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 6% |
| 3 Years: | 5% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 6% |
| 3 Years: | -10% |
| 1 Year: | -19% |
| Return on Equity | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 18% |
| 3 Years: | 16% |
| Last Year: | 13% |
Last Updated: September 5, 2025, 4:25 am
Balance Sheet
Last Updated: October 10, 2025, 2:02 pm
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 35 | 35 | 35 | 35 | 35 | 35 | 35 | 35 | 35 | 35 | 35 |
| Reserves | 342 | 412 | 539 | 683 | 841 | 1,032 | 1,266 | 1,539 | 1,847 | 2,144 | 2,327 |
| Borrowings | 451 | 412 | 393 | 348 | 298 | 396 | 289 | 421 | 327 | 187 | 210 |
| Other Liabilities | 231 | 250 | 315 | 385 | 389 | 348 | 458 | 602 | 518 | 539 | 877 |
| Total Liabilities | 1,060 | 1,109 | 1,283 | 1,452 | 1,563 | 1,812 | 2,049 | 2,597 | 2,728 | 2,906 | 3,450 |
| Fixed Assets | 459 | 436 | 456 | 447 | 519 | 748 | 712 | 760 | 923 | 973 | 1,030 |
| CWIP | 7 | 51 | 10 | 25 | 83 | 66 | 124 | 205 | 139 | 158 | 262 |
| Investments | 0 | 0 | 0 | 0 | 0 | 6 | 43 | 0 | 0 | 198 | 299 |
| Other Assets | 594 | 623 | 817 | 980 | 962 | 992 | 1,170 | 1,630 | 1,665 | 1,576 | 1,859 |
| Total Assets | 1,060 | 1,109 | 1,283 | 1,452 | 1,563 | 1,812 | 2,049 | 2,597 | 2,728 | 2,906 | 3,450 |
Below is a detailed analysis of the balance sheet data for Galaxy Surfactants Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 35.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 35.00 Cr..
- For Reserves, as of Mar 2025, the value is 2,327.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,144.00 Cr. (Mar 2024) to 2,327.00 Cr., marking an increase of 183.00 Cr..
- For Borrowings, as of Mar 2025, the value is 210.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 187.00 Cr. (Mar 2024) to 210.00 Cr., marking an increase of 23.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 877.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 539.00 Cr. (Mar 2024) to 877.00 Cr., marking an increase of 338.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 3,450.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,906.00 Cr. (Mar 2024) to 3,450.00 Cr., marking an increase of 544.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 1,030.00 Cr.. The value appears strong and on an upward trend. It has increased from 973.00 Cr. (Mar 2024) to 1,030.00 Cr., marking an increase of 57.00 Cr..
- For CWIP, as of Mar 2025, the value is 262.00 Cr.. The value appears strong and on an upward trend. It has increased from 158.00 Cr. (Mar 2024) to 262.00 Cr., marking an increase of 104.00 Cr..
- For Investments, as of Mar 2025, the value is 299.00 Cr.. The value appears strong and on an upward trend. It has increased from 198.00 Cr. (Mar 2024) to 299.00 Cr., marking an increase of 101.00 Cr..
- For Other Assets, as of Mar 2025, the value is 1,859.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,576.00 Cr. (Mar 2024) to 1,859.00 Cr., marking an increase of 283.00 Cr..
- For Total Assets, as of Mar 2025, the value is 3,450.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,906.00 Cr. (Mar 2024) to 3,450.00 Cr., marking an increase of 544.00 Cr..
Notably, the Reserves (2,327.00 Cr.) exceed the Borrowings (210.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -261.00 | -176.00 | -122.00 | -60.00 | 55.00 | -27.00 | 160.00 | -20.00 | 241.00 | 275.00 | 274.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 43 | 51 | 59 | 63 | 56 | 62 | 62 | 63 | 50 | 57 | 59 |
| Inventory Days | 68 | 72 | 79 | 75 | 68 | 72 | 91 | 103 | 78 | 82 | 95 |
| Days Payable | 50 | 59 | 63 | 71 | 59 | 60 | 80 | 75 | 52 | 66 | 81 |
| Cash Conversion Cycle | 61 | 64 | 75 | 67 | 65 | 73 | 72 | 91 | 76 | 73 | 73 |
| Working Capital Days | 4 | 27 | 31 | 39 | 41 | 43 | 50 | 63 | 55 | 64 | 52 |
| ROCE % | 23% | 26% | 25% | 28% | 24% | 25% | 19% | 24% | 17% | 16% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| SBI Balanced Advantage Fund | 53,293,368 | 3.35 | 919.84 | 53,293,368 | 2025-04-22 17:25:35 | 0% |
| SBI Contra Fund | 41,173,788 | 3.01 | 710.66 | 41,173,788 | 2025-04-22 15:56:58 | 0% |
| SBI Long Term Equity Fund | 32,193,555 | 2.77 | 555.66 | 32,193,555 | 2025-04-22 17:25:35 | 0% |
| Quant ELSS Tax Saver Fund | 21,120,000 | 5.04 | 364.53 | 21,120,000 | 2025-04-22 02:17:08 | 0% |
| Franklin India Flexi Cap Fund | 16,373,000 | 2 | 282.6 | 16,373,000 | 2025-04-22 17:25:35 | 0% |
| DSP ELSS Tax Saver Fund | 13,322,785 | 1.66 | 229.95 | 13,322,785 | 2025-04-22 17:25:35 | 0% |
| SBI Arbitrage Opportunities Fund | 10,961,700 | 0.71 | 189.2 | 10,961,700 | 2025-04-22 17:25:35 | 0% |
| SBI Dividend Yield Fund | 10,000,000 | 2.68 | 172.6 | 10,000,000 | 2025-04-22 17:25:35 | 0% |
| DSP Equity Opportunities Fund | 8,922,069 | 1.45 | 153.99 | 8,922,069 | 2025-04-22 17:25:35 | 0% |
| Invesco India Arbitrage Fund | 7,836,975 | 1.07 | 127.04 | 7,836,975 | 2025-04-22 17:25:35 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 86.00 | 85.03 | 107.46 | 74.12 | 85.22 |
| Diluted EPS (Rs.) | 86.00 | 85.03 | 107.46 | 74.12 | 85.22 |
| Cash EPS (Rs.) | 117.14 | 113.20 | 131.02 | 94.17 | 106.09 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 666.44 | 614.74 | 531.04 | 444.10 | 367.11 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 666.44 | 614.74 | 531.04 | 444.10 | 367.11 |
| Revenue From Operations / Share (Rs.) | 1191.44 | 1070.35 | 1253.95 | 1039.69 | 785.35 |
| PBDIT / Share (Rs.) | 143.88 | 140.39 | 163.08 | 116.56 | 129.67 |
| PBIT / Share (Rs.) | 112.75 | 112.23 | 139.53 | 96.52 | 108.81 |
| PBT / Share (Rs.) | 107.32 | 105.92 | 133.41 | 92.89 | 105.03 |
| Net Profit / Share (Rs.) | 86.01 | 85.04 | 107.47 | 74.13 | 85.23 |
| NP After MI And SOA / Share (Rs.) | 86.01 | 85.04 | 107.47 | 74.13 | 85.23 |
| PBDIT Margin (%) | 12.07 | 13.11 | 13.00 | 11.21 | 16.51 |
| PBIT Margin (%) | 9.46 | 10.48 | 11.12 | 9.28 | 13.85 |
| PBT Margin (%) | 9.00 | 9.89 | 10.63 | 8.93 | 13.37 |
| Net Profit Margin (%) | 7.21 | 7.94 | 8.57 | 7.12 | 10.85 |
| NP After MI And SOA Margin (%) | 7.21 | 7.94 | 8.57 | 7.12 | 10.85 |
| Return on Networth / Equity (%) | 12.90 | 13.83 | 20.23 | 16.69 | 23.21 |
| Return on Capital Employeed (%) | 16.09 | 17.21 | 24.07 | 19.71 | 26.98 |
| Return On Assets (%) | 8.80 | 10.34 | 13.93 | 10.10 | 14.74 |
| Long Term Debt / Equity (X) | 0.01 | 0.02 | 0.04 | 0.05 | 0.05 |
| Total Debt / Equity (X) | 0.06 | 0.06 | 0.14 | 0.23 | 0.18 |
| Asset Turnover Ratio (%) | 1.32 | 1.34 | 1.42 | 1.34 | 1.09 |
| Current Ratio (X) | 2.14 | 2.82 | 2.36 | 1.81 | 1.87 |
| Quick Ratio (X) | 1.40 | 1.90 | 1.41 | 0.99 | 1.18 |
| Inventory Turnover Ratio (X) | 6.60 | 4.15 | 4.30 | 4.78 | 4.19 |
| Dividend Payout Ratio (NP) (%) | 20.93 | 4.70 | 33.50 | 5.39 | 16.42 |
| Dividend Payout Ratio (CP) (%) | 15.36 | 3.53 | 27.48 | 4.24 | 13.19 |
| Earning Retention Ratio (%) | 79.07 | 95.30 | 66.50 | 94.61 | 83.58 |
| Cash Earning Retention Ratio (%) | 84.64 | 96.47 | 72.52 | 95.76 | 86.81 |
| Interest Coverage Ratio (X) | 26.50 | 22.22 | 26.64 | 32.16 | 34.25 |
| Interest Coverage Ratio (Post Tax) (X) | 16.84 | 14.46 | 18.56 | 21.45 | 23.51 |
| Enterprise Value (Cr.) | 7197.68 | 7937.75 | 8295.42 | 10453.78 | 9184.23 |
| EV / Net Operating Revenue (X) | 1.70 | 2.09 | 1.87 | 2.84 | 3.30 |
| EV / EBITDA (X) | 14.11 | 15.95 | 14.35 | 25.30 | 19.98 |
| MarketCap / Net Operating Revenue (X) | 1.72 | 2.12 | 1.86 | 2.76 | 3.25 |
| Retention Ratios (%) | 79.06 | 95.29 | 66.49 | 94.60 | 83.57 |
| Price / BV (X) | 3.08 | 3.69 | 4.39 | 6.45 | 6.96 |
| Price / Net Operating Revenue (X) | 1.72 | 2.12 | 1.86 | 2.76 | 3.25 |
| EarningsYield | 0.04 | 0.03 | 0.04 | 0.02 | 0.03 |
After reviewing the key financial ratios for Galaxy Surfactants Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 86.00. This value is within the healthy range. It has increased from 85.03 (Mar 24) to 86.00, marking an increase of 0.97.
- For Diluted EPS (Rs.), as of Mar 25, the value is 86.00. This value is within the healthy range. It has increased from 85.03 (Mar 24) to 86.00, marking an increase of 0.97.
- For Cash EPS (Rs.), as of Mar 25, the value is 117.14. This value is within the healthy range. It has increased from 113.20 (Mar 24) to 117.14, marking an increase of 3.94.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 666.44. It has increased from 614.74 (Mar 24) to 666.44, marking an increase of 51.70.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 666.44. It has increased from 614.74 (Mar 24) to 666.44, marking an increase of 51.70.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1,191.44. It has increased from 1,070.35 (Mar 24) to 1,191.44, marking an increase of 121.09.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 143.88. This value is within the healthy range. It has increased from 140.39 (Mar 24) to 143.88, marking an increase of 3.49.
- For PBIT / Share (Rs.), as of Mar 25, the value is 112.75. This value is within the healthy range. It has increased from 112.23 (Mar 24) to 112.75, marking an increase of 0.52.
- For PBT / Share (Rs.), as of Mar 25, the value is 107.32. This value is within the healthy range. It has increased from 105.92 (Mar 24) to 107.32, marking an increase of 1.40.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 86.01. This value is within the healthy range. It has increased from 85.04 (Mar 24) to 86.01, marking an increase of 0.97.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 86.01. This value is within the healthy range. It has increased from 85.04 (Mar 24) to 86.01, marking an increase of 0.97.
- For PBDIT Margin (%), as of Mar 25, the value is 12.07. This value is within the healthy range. It has decreased from 13.11 (Mar 24) to 12.07, marking a decrease of 1.04.
- For PBIT Margin (%), as of Mar 25, the value is 9.46. This value is below the healthy minimum of 10. It has decreased from 10.48 (Mar 24) to 9.46, marking a decrease of 1.02.
- For PBT Margin (%), as of Mar 25, the value is 9.00. This value is below the healthy minimum of 10. It has decreased from 9.89 (Mar 24) to 9.00, marking a decrease of 0.89.
- For Net Profit Margin (%), as of Mar 25, the value is 7.21. This value is within the healthy range. It has decreased from 7.94 (Mar 24) to 7.21, marking a decrease of 0.73.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 7.21. This value is below the healthy minimum of 8. It has decreased from 7.94 (Mar 24) to 7.21, marking a decrease of 0.73.
- For Return on Networth / Equity (%), as of Mar 25, the value is 12.90. This value is below the healthy minimum of 15. It has decreased from 13.83 (Mar 24) to 12.90, marking a decrease of 0.93.
- For Return on Capital Employeed (%), as of Mar 25, the value is 16.09. This value is within the healthy range. It has decreased from 17.21 (Mar 24) to 16.09, marking a decrease of 1.12.
- For Return On Assets (%), as of Mar 25, the value is 8.80. This value is within the healthy range. It has decreased from 10.34 (Mar 24) to 8.80, marking a decrease of 1.54.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has decreased from 0.02 (Mar 24) to 0.01, marking a decrease of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.06. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.06.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.32. It has decreased from 1.34 (Mar 24) to 1.32, marking a decrease of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 2.14. This value is within the healthy range. It has decreased from 2.82 (Mar 24) to 2.14, marking a decrease of 0.68.
- For Quick Ratio (X), as of Mar 25, the value is 1.40. This value is within the healthy range. It has decreased from 1.90 (Mar 24) to 1.40, marking a decrease of 0.50.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.60. This value is within the healthy range. It has increased from 4.15 (Mar 24) to 6.60, marking an increase of 2.45.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 20.93. This value is within the healthy range. It has increased from 4.70 (Mar 24) to 20.93, marking an increase of 16.23.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 15.36. This value is below the healthy minimum of 20. It has increased from 3.53 (Mar 24) to 15.36, marking an increase of 11.83.
- For Earning Retention Ratio (%), as of Mar 25, the value is 79.07. This value exceeds the healthy maximum of 70. It has decreased from 95.30 (Mar 24) to 79.07, marking a decrease of 16.23.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 84.64. This value exceeds the healthy maximum of 70. It has decreased from 96.47 (Mar 24) to 84.64, marking a decrease of 11.83.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 26.50. This value is within the healthy range. It has increased from 22.22 (Mar 24) to 26.50, marking an increase of 4.28.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 16.84. This value is within the healthy range. It has increased from 14.46 (Mar 24) to 16.84, marking an increase of 2.38.
- For Enterprise Value (Cr.), as of Mar 25, the value is 7,197.68. It has decreased from 7,937.75 (Mar 24) to 7,197.68, marking a decrease of 740.07.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.70. This value is within the healthy range. It has decreased from 2.09 (Mar 24) to 1.70, marking a decrease of 0.39.
- For EV / EBITDA (X), as of Mar 25, the value is 14.11. This value is within the healthy range. It has decreased from 15.95 (Mar 24) to 14.11, marking a decrease of 1.84.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.72. This value is within the healthy range. It has decreased from 2.12 (Mar 24) to 1.72, marking a decrease of 0.40.
- For Retention Ratios (%), as of Mar 25, the value is 79.06. This value exceeds the healthy maximum of 70. It has decreased from 95.29 (Mar 24) to 79.06, marking a decrease of 16.23.
- For Price / BV (X), as of Mar 25, the value is 3.08. This value exceeds the healthy maximum of 3. It has decreased from 3.69 (Mar 24) to 3.08, marking a decrease of 0.61.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.72. This value is within the healthy range. It has decreased from 2.12 (Mar 24) to 1.72, marking a decrease of 0.40.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.04, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Galaxy Surfactants Ltd:
- Net Profit Margin: 7.21%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 16.09% (Industry Average ROCE: 10.56%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 12.9% (Industry Average ROE: 9.87%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 16.84
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.4
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 25 (Industry average Stock P/E: 147.04)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.06
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 7.21%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Gas Transmission/Marketing | GAIL Bhawan 16, Bhikaiji Cama Place, New Delhi Delhi 110066 | shareholders@gail.co.in https://www.gailonline.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Sandeep Kumar Gupta | Chairman & Managing Director |
| Mr. Rakesh Kumar Jain | Director - Finance & CFO |
| Mr. Deepak Gupta | Director - Projects |
| Mr. Ayush Gupta | Director - Human Resources |
| Mr. Rajeev Kumar Singhal | Director - Business Development |
| Mr. Sanjay Kumar | Director - Marketing |
| Mr. Akhilesh Jain | Non Official Independent Director |
| Mr. Sanjay Kashyap | Non Official Independent Director |
| Mrs. Kangabam Inaocha Devi | Non Official Independent Director |
| Mr. Yajurvendra Anil Mahajan | Non Official Independent Director |
| Ms. Kamini Chauhan Ratan | Government Nominee Director |
| Mr. Kushagra Mittal | Government Nominee Director |
FAQ
What is the intrinsic value of Galaxy Surfactants Ltd?
Galaxy Surfactants Ltd's intrinsic value (as of 01 December 2025) is 1951.54 which is 3.48% lower the current market price of 2,022.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 7,165 Cr. market cap, FY2025-2026 high/low of 2,960/2,016, reserves of ₹2,327 Cr, and liabilities of 3,450 Cr.
What is the Market Cap of Galaxy Surfactants Ltd?
The Market Cap of Galaxy Surfactants Ltd is 7,165 Cr..
What is the current Stock Price of Galaxy Surfactants Ltd as on 01 December 2025?
The current stock price of Galaxy Surfactants Ltd as on 01 December 2025 is 2,022.
What is the High / Low of Galaxy Surfactants Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Galaxy Surfactants Ltd stocks is 2,960/2,016.
What is the Stock P/E of Galaxy Surfactants Ltd?
The Stock P/E of Galaxy Surfactants Ltd is 25.0.
What is the Book Value of Galaxy Surfactants Ltd?
The Book Value of Galaxy Surfactants Ltd is 715.
What is the Dividend Yield of Galaxy Surfactants Ltd?
The Dividend Yield of Galaxy Surfactants Ltd is 1.09 %.
What is the ROCE of Galaxy Surfactants Ltd?
The ROCE of Galaxy Surfactants Ltd is 16.2 %.
What is the ROE of Galaxy Surfactants Ltd?
The ROE of Galaxy Surfactants Ltd is 13.5 %.
What is the Face Value of Galaxy Surfactants Ltd?
The Face Value of Galaxy Surfactants Ltd is 10.0.